Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 785 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy 10% owner bought 62,000 shares at $13.13 ($814,196)
  5. 4 Open-market buy 10% owner bought 15,000 shares at an average $13.05 ($195,681)
  6. 4 Open-market buy 10% owner bought 200,000 shares at an average $13.04 ($2,608,707)
  7. 4 Grant or award Director acquired 16,495 shares (grant or award)
  8. 4 Grant or award Director acquired 16,495 shares (grant or award)
  9. 4 Grant or award Director acquired 16,495 shares (grant or award)
  10. 4 Grant or award Director acquired 16,495 shares (grant or award)
  11. 4 Grant or award Director acquired 16,495 shares (grant or award)
  12. 4 Grant or award Director acquired 16,495 shares (grant or award)
  13. 4 Shares withheld for taxes Chief Accounting Officer gave up 784 shares (to pay taxes)
  14. 4/A Open-market buy 10% owner bought 96,000 shares at an average $13.22 ($1,269,375)
  15. 4 Open-market buy 10% owner bought 60,000 shares at an average $13.07 ($784,228)
  16. 4 Open-market buy 10% owner bought 290,000 shares at $12.34 ($3,577,411)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Chief Accounting Officer acquired 14,344 shares (grant or award)
  19. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $10.87 ($32,603)
  20. 4 Shares withheld for taxes Chief Accounting Officer gave up 1,852 shares (to pay taxes)

Page 4 of 39 · 776 filings